Sign in

    Robert Spignesi

    President and CEO at RRapid Micro Biosystems Inc
    Since October 2014
    Age
    55 years
    Education
    Holds an M.B.A. from Columbia University and a B.S. in Economics from the United States Military Academy at West Point.
    Tenure
    Joined RPID as President and Chief Executive Officer in October 2014 and has served on its Board since then.

    Also at Rapid Micro Biosystems Inc

    JW
    John Wilson
    Chief Operating Officer
    SW
    Sean Wirtjes
    Chief Financial Officer

    About

    Robert Spignesi has demonstrated a robust blend of leadership and strategic vision throughout his career. At RPID, he has led initiatives that improved gross margins and exceeded revenue guidance, contributing significantly to the company’s success.

    Before joining RPID, he built an impressive track record in high-impact roles, including serving as Vice President & General Manager, Americas at Thermo Fisher Scientific and as Vice President of Global Strategy, Business Development, and Marketing at Fisher Scientific. His early career as an Aviation Officer with the U.S. Army further instilled a strong sense of discipline and strategic thinking.

    His tenure at RPID is marked by forward-thinking achievements such as forging key strategic agreements, including the global Distribution and Collaboration Agreement with MilliporeSigma, reflecting his commitment to sustainable growth and operational excellence. These accomplishments underscore a career built on deep industry expertise and innovative leadership.

    $RPID Performance Under Robert Spignesi

    Past Roles

    OrganizationRoleDate RangeDetails
    Thermo Fisher ScientificVice President & General Manager, Americas of the Microbiology DivisionN/AN/A
    Fisher ScientificVice President of Global Strategy, Business Development, and MarketingN/AN/A
    U.S. ArmyAviation OfficerN/AN/A

    Fixed Compensation

    Data from  FY 2023
    Component NameAmountPayment ScheduleAdditional Details
    Base Salary$616,512 Annual 20234% increase from 2022
    Other Compensation$34,990 Annual 2023Includes $12,075 (401(k) matching) , $520 (life insurance premiums) , $22,395 (medical insurance premiums)

    Performance Compensation

    Data from  FY 2023

    Annual Performance Bonus (Cash Incentive)

    MetricWeight (%) Achievement (%) Earned Payout (%)
    Commercial Execution and Revenue Growth50% 76% 29%
    New Product Development20% 100% 20%
    Customer Experience10% 127% 13%
    Gross Margin Improvement10% 0% 0%
    Employee Engagement, Recruitment, and Development10% 200% 20%
    Total100%N/A81%
    • Target Bonus: Set at 80% of base salary of $616,512 , resulting in an approximate cash payout of $401,218.
    • Evaluation Period: 2023 with bonus payout determined in January 2024.
    • Vesting: This cash incentive is paid outright with no vesting schedule.

    Performance-Based Restricted Stock Units (PRSUs)

    • Outstanding Units: 380,975 PRSUs as of December 31, 2023.
    • Market Value: $281,922 at a trading price of $0.74 per share.
    • Grant Date Stock Price: $1.22 (weighted average fair value).
    • Vesting Schedule: Vests upon achievement of specified corporate performance goals prior to March 10, 2027 and fully vests upon a Change of Control.
    • Performance Metrics: No detailed performance thresholds or targets for the RSUs are provided.